Congress trades in Grifols (GRFS)
Healthcare · Drug Manufacturers - General
1 member of Congress has disclosed 2 trades in Grifols (GRFS) since 2023: 1 buy and 1 sale. The most recent was disclosed on Apr 17, 2023.
- Trades disclosed
- 2
- Members trading
- 1
- Buys / sells
- 1 / 1
- Reported value
- $2K–$30K
Who traded GRFS
MemberBuysSalesLast disclosed
- Rep. Daniel S. Goldman (D-NY-10)1 buy · 1 sale11Apr 17, 2023
All trades
DisclosedTradeAmount
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 31, 2023 · disclosed Apr 17, 2023
- Mar 20, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Feb 27, 2023 · disclosed Mar 20, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.